Pulsenmore Ltd., a medical device company, engages in the research, development, manufacture, marketing, and sale of portable ultrasound solutions. The company provides Pulsenmore ES and Pulsenmore FC products in the United States, the United Kingdom, Northern Ireland, and Europe. The company was incorporated in 2014 and is based in Omer, Israel.…
Pulsenmore Strengthens U.S. Commercial Leadership, Appoints Med-Tech Veteran David Woods as Chief Commercial Officer
Pulsenmore (NASDAQ: PLSM) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 71 employees.
The shares were at 1.290 USD on 20 November 2026. Its 52-week range is 1.270 USD to 12.97 USD: the price is 90.1% below the high and 1.6% above the low.
Its market capitalisation is 8.39M USD.
Pulsenmore reports return on equity of -19.1%, an operating margin of 0.0% and revenue up 52.0% year over year.
Its Piotroski F-score is 3 out of 9, a weak reading of its financial health.
No upcoming events tracked.